Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Psychemedics Corporation

Market Cap 9.79M 8.44M 7.77M 7.29M 13.69M 925M 13.82M 91.82M 35.87M 453M 36.74M 35.96M 1.57B P/E Ratio 2023
-4.09x
P/E Ratio 2024 -7x
Enterprise Value 9.54M 8.22M 7.57M 7.1M 13.34M 902M 13.47M 89.46M 34.95M 442M 35.8M 35.04M 1.53B EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
Current month-8.33%
1 month-8.33%
3 months+51.72%
6 months+25.00%
Current year+37.50%
1 week 2.2
Extreme 2.2
2.2
1 month 2.2
Extreme 2.2
2.2
Current year 1.33
Extreme 1.33
2.5
1 year 1.33
Extreme 1.33
2.5
3 years 1.11
Extreme 1.11
5.15
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 2023-08-16
Director of Finance/CFO 36 2023-11-26
Corporate Officer/Principal 40 2023-09-20
Director TitleAgeSince
Director/Board Member 64 2021-03-15
Director/Board Member 58 2022-04-03
Director/Board Member 64 2022-08-11
Date Insider Type Main position Quantity % Market Cap.
24-12-12
Powell Anderson Capital Partners
BuyCompany 159,700 2.7093%
24-12-09
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
24-12-09Sell

Director

320,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-0.45%-52.79% 13.46M
+2.31%+1.64%+28.96%+327.78% 30.37B
-1.29%+3.10%-25.85%-43.04% 7.04B
+0.60%+5.34%-0.66%+86.62% 4.46B
+0.91%+5.15%+9.43%+61.82% 2.82B
-4.65%+12.19%+24.88%-25.62% 1.79B
+2.34%+18.38%-8.32%+737.70% 1.78B
-1.98%+3.16%-13.11%-65.92% 1.73B
-1.51%+2.53%+13.14%-6.32% 1.63B
-0.56%+22.92% - - 1.53B
Average -0.39%+3.88%+3.11%+113.36% 5.32B
Weighted average by Cap. +0.99%+1.21%+14.52%+219.94%

Financials

2023 2024
Net sales 22.1M 19.05M 17.53M 16.44M 30.89M 2.09B 31.2M 207M 80.95M 1.02B 82.93M 81.17M 3.54B 19.68M 16.97M 15.61M 14.65M 27.52M 1.86B 27.79M 185M 72.11M 911M 73.87M 72.31M 3.15B
Net income -4.15M -3.58M -3.3M -3.09M -5.81M -393M -5.86M -38.95M -15.22M -192M -15.59M -15.26M -665M -1.86M -1.6M -1.48M -1.38M -2.6M -176M -2.63M -17.45M -6.82M -86.13M -6.98M -6.84M -298M
Net Debt 334K 288K 265K 249K 467K 31.57M 472K 3.13M 1.22M 15.46M 1.25M 1.23M 53.49M -251K -216K -199K -187K -351K -23.72M -354K -2.35M -919K -11.62M -942K -922K -40.2M
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. PMDI Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!